These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 222112)

  • 1. Sequence of motor nerve terminal involvement in acrylamide neuropathy.
    Jennekens FG; Veldman H; Schotman P; Gispen WH
    Acta Neuropathol; 1979 Apr; 46(1-2):57-63. PubMed ID: 222112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication.
    Schaumburg HH; Wiśniewski HM; Spencer PS
    J Neuropathol Exp Neurol; 1974 Apr; 33(2):260-84. PubMed ID: 4362700
    [No Abstract]   [Full Text] [Related]  

  • 4. Unmyelinated nerve fibres in feline acrylamide neuropathy.
    Post EJ
    Acta Neuropathol; 1978 Apr; 42(1):19-24. PubMed ID: 207070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal sprouting of motor nerve in acrylamide-intoxicated rats with progressive weakness.
    Madrid RG; Ohnishi A; Hachisuka K; Murai Y
    Environ Res; 1993 Feb; 60(2):233-41. PubMed ID: 8472652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor end-plate fine structure in acrylamide dying-back neuropathy: a sequential morphometric study.
    Tsujihata M; Engel AG; Lambert EH
    Neurology; 1974 Sep; 24(9):849-56. PubMed ID: 4368933
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and morphologic characterization of acrylamide peripheral neuropathy.
    Lehning EJ; Persaud A; Dyer KR; Jortner BS; LoPachin RM
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):211-21. PubMed ID: 9707497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vacor neuropathy: ultrastructural and axonal transport studies.
    Watson DF; Griffin JW
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):96-108. PubMed ID: 2432196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The axon reaction in spinal ganglion neurons of acrylamide-treated rats.
    Jones HB; Cavanagh JB
    Acta Neuropathol; 1986; 71(1-2):55-63. PubMed ID: 3022537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrylamide neuropathy in rats. An electron microscopic study of degeneration and regeneration.
    Suzuki K; Pfaff LD
    Acta Neuropathol; 1973 May; 24(3):197-213. PubMed ID: 4357171
    [No Abstract]   [Full Text] [Related]  

  • 12. Nervous system degeneration produced by acrylamide monomer.
    Spencer PS; Schaumburg HH
    Environ Health Perspect; 1975 Jun; 11():129-33. PubMed ID: 170076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration.
    Gold BG; Griffin JW; Price DL
    J Neurosci; 1985 Jul; 5(7):1755-68. PubMed ID: 2410575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in the vagus nerve in canine acrylamide neuropathy.
    Satchell PM; McLeod JG; Harper B; Goodman AH
    J Neurol Neurosurg Psychiatry; 1982 Jul; 45(7):609-19. PubMed ID: 6288880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric evaluation of degenerative and regenerative changes in isoniazid-induced neuropathy.
    Chua CL; Ohnishi A; Tateishi J; Kuroiwa Y
    Acta Neuropathol; 1983; 60(3-4):183-93. PubMed ID: 6310925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overwork weakness in rats with acrylamide neuropathy.
    Okajima Y; Maloney FP
    Am J Phys Med Rehabil; 1989 Apr; 68(2):66-9. PubMed ID: 2539170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin-induced neuropathy in an animal model.
    Russell JW; Gill JS; Sorenson EJ; Schultz DA; Windebank AJ
    J Neurol Sci; 2001 Nov; 192(1-2):71-80. PubMed ID: 11701155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of thioctic acid on motor nerve terminals in acrylamide-poisoned rats.
    Kemplay S; Martin P; Wilson S
    Neuropathol Appl Neurobiol; 1988; 14(4):275-88. PubMed ID: 3146707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of degenerative changes in INH neuropathy. Further evidence for focal axonal lesions.
    Jacobs JM; Miller RH; Cavanagh JB
    Acta Neuropathol; 1979 Oct; 48(1):1-9. PubMed ID: 228520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow recovery of central axons in acrylamide neuropathy.
    Kaji R; Liu Y; Duckett S; Sumner AJ
    Muscle Nerve; 1989 Oct; 12(10):816-26. PubMed ID: 2558312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.